Expression and Characterization of the IPM 150 Gene Ž / IMPG1 Product, a Novel Human Photoreceptor Cell-Associated Chondroitin
Total Page:16
File Type:pdf, Size:1020Kb
Matrix Biology 18Ž. 1999 509]518 Expression and characterization of the IPM 150 gene ž/IMPG1 product, a novel human photoreceptor cell-associated chondroitin-sulfate proteoglycan Markus H. Kuehn, Gregory S. HagemanU Department of Ophthalmology and Visual Sciences, The Uni¨ersity of Iowa, 11190E PFP, 200 Hawkins Dri¨e, Iowa, IA 52240, USA Received 9 May 1999; received in revised form 29 July 1999; accepted 3 August 1999 Abstract The interphotoreceptor matrixŽ. IPM occupies the extracellular space between the apical surface of the retinal pigmented epithelium and the external limiting membrane of the neural retina. This space contains two chondroitin sulfate proteogly- cans, designated IPM 150 and IPM 200, which are likely to effect retinal adhesion and photoreceptor survival. In an effort to characterize human IPM 150, several cDNA clones encoding its core protein have been isolated from a human retinal cDNA library. Translation of overlapping cDNA sequences yields a novel core protein with a predicted molecular mass of 89.3 kDa. Northern and dot-blot analyses as well as the isolation of expressed sequence tags demonstrate that IPM 150 mRNA is expressed not only in the neural retina but also in several other non-ocular tissues. In situ hybridization analyses indicate that, in the eye, IPM 150 mRNA is expressed speci®cally by cone and rod photoreceptor cells. Characterization of IPM 150 proteoglycan core protein and identi®cation of its site of synthesis are important steps towards understanding the architecture and biology of the IPM. Q 1999 Elsevier Science B.V.rInternational Society of Matrix Biology. All rights reserved. Keywords: cDNA; Chondroitin-sulfate proteoglycan; Interphotoreceptor matrix; Photoreceptor; Retina 1. Introduction ates signi®cant functional interactions between the neural retina and the RPE, including the exchange of Invagination of the optic vesicle during vertebrate metabolites and catabolic byproducts, regulation of ocular morphogenesis results in the formation of a the ionic milieu, mediation of retinal adhesion, se- unique extracellularŽ. `subretinal' space between the questration of growth factors, and maintenance of apical surfaces of the neural retina and the retinal photoreceptor polarization, orientation, turnover and pigmented epitheliumŽ. RPE . Photoreceptor cell outer viabilityŽ Hewitt et al., 1990; Hageman and Johnson, segments project into this compartment which is oc- 1991a,b; Hageman et al., 1991. cupied by the interphotoreceptor matrixŽ. IPM , an IPM glycoconjugates mediate the physical attach- extracellular matrix comprised of an array of proteins, ment of the neural retina to the RPE, and although glycoproteins, and proteoglycansŽ Hageman and John- the precise molecular mechanisms involved have not son, 1991a; Mieziewska, 1996; Hageman and Kuehn, been elucidated, chondroitin sulfate proteoglycans ap- 1998. There is general consensus that the IPM medi- pear to be crucial in this functionŽ Holly®eld et al., 1989; Yao et al., 1990, 1992, 1994; Johnson and Hage- man, 1991; Lazarus and Hageman, 1992; Marmor et U Corresponding author. al., 1994; Hageman et al., 1995. Cone photoreceptor E-mail address: [email protected]Ž. G.S. Hageman cells are associated with cone matrix sheathsŽ. CMS , 0945-053Xr99r$ - see front matter Q 1999 Elsevier Science B.V.rInternational Society of Matrix Biology. All rights reserved. PII: S 0 9 4 5 - 0 5 3 XŽ. 9 9 0 0 0 4 3 - 8 510 M.H. Kuehn, G.S. Hageman Matrix Biology 18() 1999 509᎐518 distinct domains of the IPM that contain chondroitin 2. Materials and methods 6-sulfate proteoglycan and have ®rm attachments to both RPE cells and the neural retinaŽ Johnson et al., 2.1. Tissues 1986; Blanks et al., 1988. This adhesive system is suf®ciently strong to detach the RPE or tear the CMS Human eyes were obtained from MidAmerica following manual separation of the neural retina from Transplant ServicesŽ. St. Louis, MO, USA and the the RPEŽ. Hageman et al., 1995 . Furthermore, enzy- University of Iowa Lion's Eye BankŽ Iowa City, IA, matic cleavage of IPM-associated chondroitin sulfate USA. and processed within 3 h of cardiac cessation glycosaminoglycans leads to a rapid decrease of reti- under approved Institutional Review Board protocols. nal adhesiveness in both rabbits and primates in vivo Eyes and other organs were obtained from cynomol- Ž.Yao et al., 1990, 1994 . Adhesion is restored several gus macaque monkeys Ž.Macaca fascicularis immedi- days after injection, concomitant with the de novo ately after barbiturate-induced euthanasia. All ani- biosynthesis of IPM chondroitin sulfate proteoglycans mals were treated in conformity with the NIH `Guide Ž.Yao et al., 1992 . In addition, disruption of proteogly- for the Care and Use of Laboratory Animals', and the can synthesis in vivo leads to loss of CMS-associated established guidelines of St. Louis University and the chondroitin 6-sulfate proteoglycans, IPM disruption, University of Iowa. localized retinal detachments and photoreceptor outer segment degenerationŽ. Lazarus and Hageman, 1992 . 2.2. Isolation of IPM Other studies have documented a correlation between changes in IPM composition and photore- Human and monkey neural retinas were separated ceptor cell degeneration in various ocular diseases from the RPE and incubated in a 10-mM phosphate ŽLaVail et al., 1981; Blanks et al., 1987, 1993; Johnson buffered salineŽ. PBS , pH 7.4, containing a cocktail of et al., 1989; Hageman and Kuehn, 1998. In the RCS protease inhibitors as described earlierŽ Hageman et rat and the MPS VII mouse, for example, loss of IPM al., 1991. The isolated retinas were then placed in 4 chondroitin 6-sulfate proteoglycan precedes de- M urea solution in PBS containing 0.5% NP-40 and tectable photoreceptor degenerationŽ Porrello and protease inhibitors until the IPM dissociated from the LaVail, 1986; Johnson et al., 1989; Chu et al., 1992; photoreceptor cells. The resulting sheets of insoluble Lazarus et al., 1993. IPM were isolated, pelleted by centrifugation, resus- Ž.᎐ Immunohistochemical and biochemical investiga- pended in PBS and repelleted 7 10 times to remove tions have demonstrated that CMSs contain two ma- any remaining soluble components. jor chondroitin 6-sulfate proteoglycansŽ Hageman and Johnson, 1986, 1987. which, upon digestion with 2.3. Amino acid sequencing chondroitinase ABC, migrate in SDS-polyacrylamide gels with apparent molecular weights of 150 kDa and Aqueous-insoluble human and monkey IPM prepa- 200 kDaŽ. Hageman and Johnson, 1991a . These pro- rations were homogenized and digested with chon- teoglycans are herein referred to as IPM 150 and droitin ABC lyaseŽ.Ž. E.C. 4.2.2.4 Seikagaku in the Њ IPM 200, respectively. They comprise a signi®cant presence of protease inhibitors, for 2 h at 37 C. Pro- portion of the IPM and they are the only IPM con- teins were separated on SDS-polyacrylamide gels, transferred to PVDF membranes and brie¯y stained stituents bound by AC6S antibodies on Western blots with 0.1% Coomassie blue. The appropriate bands of IPM preparations, suggesting that they represent were excised and NH -terminal amino acid sequences the same molecules, which mediate retinal adhesion 2 for IPM 150 were determined by Edman degradation in vivo. Ž.Stone et al., 1992 . In order to characterize further the structure and Other amino acid sequences were obtained from function of IPM 150, we have determined the cDNA fragments of IPM 150 generated by an `in-gel' trypsin sequence encoding its core protein. The results pre- digestion protocol. Brie¯y, chondroitinase ABC- sented herein show that IPM 150 is expressed by rod treated IPM preparations were separated by SDS- and cone photoreceptor cells in the retina as well as PAGE, the gels were stained with 0.1% Coomassie various other tissues and possesses a unique se- and IPM 150 was identi®ed and excised. Gel strips quence, bearing no signi®cant homology to any other were incubated at 37ЊC for 24 h in a 1:25Ž. ww ratio protein. It is anticipated that this information will not of trypsin to protein. Following incubation, the pep- only aid in subsequent studies of the role of IPM tides were extractedŽ. Stone and Williams, 1993 and constituents in the retina but during molecular char- fractionated by reverse phase HPLC in 0.2 ml of 2 M acterization of other tissues expressing this proteogly- urea solution. Separated peptides were subjected to can as well. amino acid sequencing. M.H. Kuehn, G.S. Hageman Matrix Biology 18() 1999 509᎐518 511 2.4. Reerse transcription-polymerase chain reaction 2.6. cDNA sequencing ()RT-PCR Subcloned cDNA fragments were manually se- Total retinal RNA was isolated from monkey and quenced by dideoxy nucleotide chain termination Ž. human retinas using RNAStat-60 reagentŽ. Tel-Test Sanger et al., 1977 using the Sequenase 2.0 sequenc- Ž. and 100 ngtube were reverse-transcribed using ran- ing Kit Amersham . Both strands were analyzed at dom hexamer primers and the GeneAmpᮋ RNA PCR least twice using either vector-speci®c primers or cus- KitŽ. Perkin Elmer Cetus . For the initial experiments, tom oligonucleotide primers. Comparisons between monkey retinal cDNA was ampli®ed for 25 cycles the obtained sequences and those in the NCBI using a degenerate sense PCR primerŽ 5Ј-TATTAG- databases were executed using the BLAST algorithm Ž. GAAT TCCATYTTYT TYCCIAAYGG-3Ј., designed Altschul et al., 1990 in the MacVector software Ž. using the amino acid sequence of the monkey IPM package Kodak International Biotechnologies or the 150 amino-terminus and a degenerate antisense NCBI web server. primerŽ 5Ј-TTICCIGCIA GYTCYTGRTA RTAIGG- 3Ј. which was designed based on the sequence of 2.7. Northern blot analyses tryptic peptide ࠻70, derived from human IPM 150. During the synthesis of these primers, inosine residues Total RNA from various ocular and non-ocular were used in positions of complete degeneracy. An tissues was isolated as described above and separated ampli®cation product of 580 bp was isolated and on agarose gels containing formaldehyde.